Evidence map›Paper›PMID 42975745›Full record

ArticleApoptosis : an international journal on programmed cell death2026

Nr1d1 regulates ER-mitochondria interactions and calcium transfer, and muscle cell apoptosis.

Alexis Boulinguiez, Christian Duhem, Alicia Mayeuf-Louchart, Nadia Bendridi, Jérôme Kluza, Yasmine Sebti, Nicolas Barois, Elisabeth Werkmeister, Quentin Thorel, Justine Beauchamp and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alexis BoulinguiezUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Christian DuhemUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Alicia Mayeuf-LouchartUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Nadia BendridiCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, Lyon, 69008, France.
Jérôme KluzaUniv. Lille, Inserm, CHU Lille, CNRS, Institut Pasteur de Lille, U1366-UMR9020 - CRCLille - Cancer Research Center of Lille, Lille, F-59000, France.
Yasmine SebtiUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Nicolas BaroisUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UMS 2014-PLBS, Lille, France.
Elisabeth WerkmeisterUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UMS 2014-PLBS, Lille, France.
Quentin ThorelUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Justine BeauchampUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Stéphane DelhayeUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Lise FerriUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Marie CouvelaereUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Cécilia BellengierUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Mathilde ZecchinUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Benoît PourcetUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Jennifer RieussetCarMeN Laboratory, INSERM U1060, INRA U1397, University Lyon 1, Lyon, 69008, France.
Bart StaelsUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France.
Hélène DuezUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France. helene.duez@inserm.fr.
Steve LancelUniv. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, Lille, F-59000, France. steve.lancel@univ-lille.fr.ORCID http://orcid.org/0000-0002-3292-5433

Funding

Agence Nationale de la Recherche ANR-10-LABX-0046European Research Council 694717Fondation pour la Recherche Médicale FDT20170739031French Muscular Dystrophy Association 22281
6 · The paper itself

Abstract

The Endoplasmic Reticulum (ER) and mitochondria interact within specific structures called Mitochondria-ER Contact sites (MERCs). MERCs are involved in calcium exchange and apoptosis. However, factors controlling MERC formation and functions are not fully identified. Since the nuclear receptor Nr1d1 (also known as Rev-erbα) modulates both mitochondrial function and reticular calcium homeostasis in skeletal muscle, we explored whether Nr1d1 could also impact MERC formation and as such modulate calcium fluxes and apoptosis of muscle cells upon ER stress.Here, we observe that Nr1d1 overexpression in C2C12 muscle cells and human myotubes increases MERC formation, favoring calcium transfer from the ER toward mitochondria. Upon tunicamycin-induced ER stress, Nr1d1 overexpression causes greater calcium influx into mitochondria, subsequently triggering a deeper reduction in mitochondrial efficiency and exacerbating apoptosis. Pharmacological inhibition of MERCs formation partly abolishes Nr1d1 effects on ER stress-induced calcium transfer and apoptosis.These findings identify Nr1d1 as a new modulator of MERCs in muscle cells.

Indexed as

ApoptosisCalciumEndoplasmic ReticulumMitochondriaMuscle CellsNuclear Receptor Subfamily 1, Group D, Member 1AnimalsCell LineEndoplasmic Reticulum StressHumansMiceMitochondria Associated MembranesMuscle Fibers, SkeletalMuscle, SkeletalCalciumNuclear Receptor Subfamily 1, Group D, Member 1ApoptosisCalcium transferEndoplasmic reticulumMitochondriaMitochondria-ER Contact sitesRev-erbα

Identifiers

PMID42975745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.